期刊文献+

Ki-67、VEGF在胃肠道类癌组织中的表达及其临床意义

Expressions of Ki - 67, VEGF and their clinical significances in gastrointestinal carcinoid
原文传递
导出
摘要 目的探讨胃肠道类癌中细胞增殖核抗原(Ki-67)、血管内皮生长因子(vascular endothelial growth factor,VEGF)的表达与临床病理因素的关系及其临床意义。方法采用免疫组织化学EliVisionplus两步法,检测20例胃肠道类癌中Ki-67和VEGF的表达,并与各临床病理因素进行相关性分析。结果Ki-67在胃肠道类癌中的阳性表达约为45%,与肿瘤的大小、淋巴结转移、临床分期有关(P〈0.05);VEGF的阳性表达约为85%;Ki-67和VEGF的共表达与肿瘤的大小、淋巴结转移、临床分期有关(P〈0.05)。结论胃肠道类癌中存在着Ki-67、VEGF的高表达,Ki-67的阳性表达为胃肠道类癌的的临床病理评估提供参考,而Ki-67和VEGF的阳性共表达参考意义更明显。 Objective To investigate the expressions of Ki - 67 and VEGF in gastrointestinal carcinoid,and to explore their correlations with clinicopathologieal factors and their clinical significances. Methods The expressions of Ki - 67 and VEGF in 20 cases of gastrointestinal carcinoid were assessed by immunohistochemistry (Elivision plus two -step system), and their correlations with clinicopathological factors were statistically analyzed. Results The positive rate of Ki -67 was about 45 %, and the expression of Ki - 67 was correlated with tumor size, lymph node status and clinical stage ( P 〈 0.05 ) ; The positive rate of VEGF was about 85% ; The co - expression of Ki -67 and VEGF was related to tumor size, lymph node status and clinical stages (P 〈 0.05 ). Conclusion The positive rates of Ki - 67 and VEGF are high in gastrointestinal carcinoid tumors. The positive expression of Ki -67 can provide a reference for the clinicopathological evaluation of gastrointestinal carcinoid, and the referring value of positive co - expression of Ki - 67 and VEGF is more pronounced.
出处 《临床外科杂志》 2011年第10期686-688,共3页 Journal of Clinical Surgery
关键词 胃肠道类癌 细胞增殖核抗原 血管内皮生长因子 免疫组化 gastrointestinal carcinoid Ki - 67 VEGF immunohistochemistry
  • 相关文献

参考文献7

  • 1Nakayama Y, Sako T, Shibao K, et al. Prognostic value of plasma vascu- lar endothelial growth factor in patients with colonrectal cancer[ J]. An- ticancer Res,2002,22 (4) :2437-2442.
  • 2Zolota V, Batistatou A, Tsamandas AC, et al. Immunohistochemical ex- pression of TGF - betal, p21WAF1, p53, Ki67, and angiogenesis in gas- tric carcinomas:a clinicopathologic study[ J]. Int J Gastrointest Cancer, 2002,32(2) :83-89.
  • 3Sokmensuer C, Gedikoglu G, Uzunalimoglu B. Importance of proliferation markers in gastrointestinal carcinoid tumors : a clinico pathologic study [ J]. Hepatogastroenterology ,2001,48 ( 39 ) :720-723.
  • 4Amarapurkar AD, Davies A, Ramage JK, et al. Proliferation of antigen MIB - 1 in metastatic carcinoid tumours removed at liver transplanta- tion:relevance to prognosis[ J ]. Eur J Gast Roenterol Hepatol,2003,15 (2) :139-143.
  • 5Pape UF,Bemdt U,Muller- Nordhom J ,et al. Prognostic factors of long- term outcome in gastroenteropancreatic neuroendocrine tumours [ J ]. En- docr Relat Cancer,2008,15 (4) : 1083-1097.
  • 6李宝江,朱志华,王军业,侯景辉,赵进明,张蓬原,姚广裕,王曦,龙浩,杨名添,戎铁.Ki67、P53、VEGF和C-erbB-2在乳腺癌组织中表达的相关性研究及其临床意义[J].癌症,2004,23(10):1176-1179. 被引量:126
  • 7Yao JC, Phan A, Hoff PM, et al. Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha - 2b [J]. J Clin 0ncol,2008,26(8):1316-1323.

二级参考文献13

  • 1Gerdes J, Schwab U, Lemke H, et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation [J]. Iht J Cancer, 1983,31 (1):13-20.
  • 2Hall PA, Levison DA, Woods AL, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms [J]. J Pathol, 1990, 162(4): 285-294.
  • 3Mullerat J, Deroide F, Winslet MC, et al. Proliferation and p53expression in anal cancer precursor lesions [J]. Anticancer Res,2003, 23 (3C): 2995-2999.
  • 4Liu M, Lawson G, Delos M, et al. Predictive value of the fraction of cancer cells immunolabeled for proliferating cell nuclear antigen or Ki67 in biopsies of head and neck carcinomas to identify lymph node metastasis: comparison with clinical and radiologic examinations [J]. Head Neck,2003,25(4): 280-288.
  • 5Tut VM, Braithwaite AL, Angus B, et al. Gyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53,wafl, pRb and Ki67 [J]. Br J Gancer,2001, 84(2): 270-275.
  • 6Bhatavdekar JM, Patel DD, Shah NG,et al. Prognostic significance of immunohisto-chemically localized biomarkers in stage Ⅱ and stage Ⅲ breast cancer: a multivariate analysis [J] . Ann Surg Oncol,2000, 7 (4): 305-311.
  • 7Vincent-Salomon A, Rousseau A, Jouve M, et al. Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapy [J]. Eur J Cancer,2004(40): 1502-1508.
  • 8Nakopoulou L, Stefanaki K, Panayotopoulou E, et al. Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: correlation with proliferation [J]. Hum Pathol,2002,33(9): 863-870.
  • 9Norberg T, Klaar S, Kaff G, et al. Increased p53 nutation frequency during tumor progression-results from a breast cancer cohort [J]. Cancer Res, 2001, 61 (22): 8317-8321.
  • 10Davidoff AM, HerndonJE, Glover NS, et al. Relation between p53overoxpression and established prognostic factors in breast cancer [J]. Surgery, 1991, 110(2): 259-264.

共引文献125

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部